Security key
00791X209
AEON Biopharma, Inc. - Class A Common Stock (AEON)
CUSIP: 00791X209
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Class A Common Stock
- Total 13F shares
- 13,518
- Total 13F value
- $4,057
- Share change
- +12,856
- SEC-reported price per share
- $0.30
- Number of holders
- 3
- Value change
- +$3,857
- Number of buys
- 1
- Shares outstanding
- 50,000,000
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
3
Top holders
3
AEON full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q2 2026
AEON Biopharma, Inc. SEC filings
AEON Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00791X209
Recent filing periods:
Ownership snapshot
Top reported holders of AEON - AEON Biopharma, Inc. - Class A Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Daewoong Co., Ltd
Disclosed value leader
Daewoong Co., Ltd
Comparable rows
15/15
Latest evidence
19 Aug 2026
3/4/5
13D/G
13F
Lead comparable stake: 50%
13D/G row: Daewoong Co., Ltd
Showing 1-6 of 15 holder rows.
Quick read
Daewoong Co., Ltd leads the comparable SEC ownership view at 50%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Daewoong Co., Ltd's linked filing trail.
Comparable ownership
Top 5
Daewoong Co., Ltd
50%
Timothy P. Lynch
13%
Stonepine Capital Management, LLC
9.9%
Jorey Chernett
9.9%
Dauntless Investment Group, LLC
9.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Daewoong Co., Ltd |
3/4/5
13D/G
10%+ Owner · Daewoong Co.,Ltd. ("DWC")
|
50%
from 13D/G
|
$13,216,715
12,009,737 shares
|
— | 21 Jan 2026 |
| Timothy P. Lynch |
13D/G
3/4/5
10%+ Owner
|
13%
|
$1,690,000
6,500,000 shares
|
$0 | 19 Aug 2026 |
| Stonepine Capital Management, LLC |
13D/G
|
9.9%
|
$5,006,155
6,892,682 shares
|
$0 | 15 Jul 2026 |
| Jorey Chernett |
13D/G
Chernett Jorey
|
9.9%
|
$564,250
1,128,500 shares
|
$0 | 27 May 2025 |
| Dauntless Investment Group, LLC |
13F
13D/G
Company
|
9.7%
from 13D/G
|
$8,984,168
12,490,154 shares
|
— | 30 Jun 2026 |
| BIGGER CAPITAL FUND L P |
13D/G
Bigger Michael
|
6.1%
|
$343,000
4,900,000 shares
|
$0 | 06 Jan 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
13,518
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
22
Q3 2026 holders
3
Holder diff
-19
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend